Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2185915Generated: October 31, 2026

1-(Piperidin-4-yl)-1,3-diazinan-2-one → N-(4-[4-(Tetrahydro-2-oxo-1(2H)-pyrimidinyl)-1-piperidinyl]-2-(4-chlorophenyl)-butyl)-N-methyl-5,6,7,8-tetrahydro-1-naphthamide

https://huagongshe.com/reaction/2185915

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(Piperidin-4-yl)-1,3-diazinan-2-oneHCID 15572666—
ReactantN-[2-(4-chlorophenyl)-4-oxobutyl]-N-methyl-5,6,7,8-tetrahydro-1-naphthamideHCID 22452671—
ProductN-(4-[4-(Tetrahydro-2-oxo-1(2H)-pyrimidinyl)-1-piperidinyl]-2-(4-chlorophenyl)-butyl)-N-methyl-5,6,7,8-tetrahydro-1-naphthamideHCID 22452692—

Reaction Steps

Using standard reductive amination conditions N-[2-(4-chlorophenyl)-4-oxobutyl]-N-methyl-5,6,7,8-tetrahydro-1-naphthamide was reacted with with 4-(tetrahydro-2-oxo-1(2H)-pyrimidinyl)piperidine and converted to the citrate salt. MS: m/z 537 (M+H). Analysis for C3H41CIN4O2.C6H8O7. H2O: calculated: C, 59.36; H, 6.87; N, 7.46; found: C, 59.42; H, 6.71; N, 7.12.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06403601B1
Source datasetuspto-grants-2002_06
ORD IDord-cfbc26dede9e4a8e88ad3eba091599e7
Source noteuspto-grants-2002_06